Tower Research Capital LLC (Trc) Syndax Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,509 shares of SNDX stock, worth $85,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,509
Previous 15,655
58.42%
Holding current value
$85,137
Previous $321,000
61.06%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$103 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$76.4 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$65.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$63.9 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$53.7 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $740M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...